Search results
Statement on the antigen composition of COVID-19 vaccines
World Health Organization· 6 days agoApril 2024 statement on the antigen composition of COVID-19 vaccines
Turning a tumor's 'shield' into a weapon against itself
Medical Xpress· 1 hour agoWang Lab researchers have now developed a new approach that turns a tumor cell's cunning defense...
Bird Flu Vaccines Could Be Available Within Weeks
newser· 55 minutes ago"We've been investing in a library of antigens to move out as quickly as possible should we begin to see a highly transmissible flu strain circulate,"...
Xyphos and Poseida to develop allogeneic cell therapies for cancer
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThe parties will combine their cell therapy platforms to create a new convertible chimeric antigen...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 18 hours agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision...
KAMR Amarillo· 2 days agoInfinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in...
New Brunswick mulls future of COVID-19 rapid tests, as virus kills 2, hospitalizes child under 4
CBC via Yahoo News· 2 days agoNew Brunswick is mulling the future of its COVID-19 rapid point-of-care testing program, as the...
Researchers discover enzymes that open new path to universal donor blood
Medical Xpress· 3 days agoThe quest to develop universal donor blood has taken a decisive step forward. Researchers at DTU and...
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack...
The Conversation via Yahoo News· 24 hours agoCancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 2 hours agoDevelopments and Clinical Progress Arbutus has made noteworthy progress in its clinical trials, particularly with imdusiran (AB-729), an RNAi therapeutic, showing promising results in reducing ...